Two separate posts in the Center for Global Health Policy’s “Science Speaks” blog report on the International Treatment as Prevention conference in Vancouver. The first post recaps an update from Stephen Becker of the Bill & Melinda Gates Foundation on Tuesday “about the Foundation’s treatment optimization activities,” writing, “According to Becker, the Foundation acknowledges that treatment will be at the center of HIV prevention efforts, but ‘no amount of treatment will obviate the need for primary prevention modalities'” (Lubinski, 4/24). The second post reports that, “[d]espite its status as one of the poorest countries in Africa and its failed effort to garner a Round 10 grant from the Global Fund to Fight AIDS, Tuberculosis and Malaria — Malawi is moving forward to implement ‘Option B+’ for pregnant women,” meaning “pregnant and lactating women are enrolled in antiretroviral therapy (ART) programs for life, regardless of CD4 count” (Lubinski, 4/24).